PRESS RELEASE published on 04/01/2025 at 15:45, 1 year 3 months ago Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement Applied DNA Sciences announces repositioning of TR8™ PGx testing service to offer tailored subpanels targeting genetic variants correlated with DPD enzyme deficiencies in cancer patients, following recent FDA safety announcement Genetic Testing Applied DNA Sciences Pharmacogenomics TR8 PGx FDA Safety Announcement
BRIEF published on 09/11/2024 at 15:05, 1 year 10 months ago Applied DNA lance le service de test Mpox Clade I et Clade II Technologie PCR Diagnostic De Santé ADN Appliqué Test Mpox Clades I Et II
BRIEF published on 09/11/2024 at 15:05, 1 year 10 months ago Applied DNA Launches Mpox Clade I and Clade II Testing Service PCR Technology Applied DNA Mpox Testing Clade I And II Health Diagnostics
PRESS RELEASE published on 09/11/2024 at 15:00, 1 year 10 months ago Applied DNA Launches Mpox Clade I and Clade II Testing Service Applied DNA Sciences expands clinical testing to include detection of Mpox Clade I and Clade II. ADCL, a NYSDOH CLEP-permitted laboratory, offers Linea Mpox Virus 1.0 Assay from Stony Brook, NY Applied DNA Sciences Linea Mpox Virus 1.0 Assay Mpox Testing ADCL Clinical Laboratory
BRIEF published on 08/23/2024 at 15:05, 1 year 10 months ago Applied DNA soumet un dossier de validation au NYSDOH pour l'extension de la détection de Mpox Clade I ADN Appliqué Clade I De Mpox Études De Validation Dosage De La Ligne Approbation Du NYSDOH
BRIEF published on 08/23/2024 at 15:05, 1 year 10 months ago Applied DNA Submits Validation Package to NYSDOH for Mpox Clade I Detection Expansion Applied DNA Mpox Clade I NYSDOH Approval Validation Studies Linea Assay
PRESS RELEASE published on 08/23/2024 at 15:00, 1 year 10 months ago Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I Applied DNA Sciences expands Linea Mpox Virus 1.0 Assay to detect mpox clade I and clade Ib in addition to clade II with 100% homology. NYSDOH review ongoing Applied DNA Sciences PCR-based DNA Technologies Mpox Clade I Linea Mpox Virus 1.0 Assay NYSDOH Review
BRIEF published on 08/19/2024 at 21:30, 1 year 10 months ago Applied DNA cherche à obtenir l'approbation d'une utilisation élargie du test Linea Mpox Virus 1.0 Mpox ADN Appliqué Clade I District De Columbia De New York Approbation Des Analyses
BRIEF published on 08/19/2024 at 21:30, 1 year 10 months ago Applied DNA To Seek Approval for Expanded Use of Linea Mpox Virus 1.0 Assay Mpox Applied DNA Clade I NYSDOH Assay Approval
PRESS RELEASE published on 08/19/2024 at 21:25, 1 year 10 months ago Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I Applied DNA Sciences intends to expand Linea™ Mpox Virus 1.0 Assay use to detect WHO-declared mpox Clade I. Validation studies underway for NYSDOH approval Applied DNA Sciences Linea™ Mpox Virus 1.0 Assay Mpox Clade I NYSDOH Approval Genetic Sequence Detection
Published on 07/14/2026 at 01:45, 2 hours 44 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 4 hours 28 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 5 hours 19 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 6 hours 54 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 8 hours 29 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/13/2026 at 22:30, 5 hours 59 minutes ago Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 7 hours 9 minutes ago Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 7 hours 11 minutes ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 7 hours 41 minutes ago EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026
Published on 07/13/2026 at 20:23, 8 hours 6 minutes ago EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations
Published on 07/13/2026 at 18:00, 10 hours 29 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 10 hours 29 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 10 hours 29 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026